All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | SEP 2025 | SEP 2024 | SEP 2023 | SEP 2022 | SEP 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $1,354 | $1,349 | $1,274 | $1,300 | $1,254 | $1,281 |
| Cost of Revenue | $168 | $160 | $140 | $153 | $141 | $130 |
| Gross Profit | $1,187 | $1,189 | $1,133 | $1,147 | $1,112 | $1,151 |
| Operating Expenses | ||||||
| Selling & Marketing | $363 | $361 | $334 | $354 | $359 | $333 |
| General & Administrative | $295 | $287 | $270 | $258 | $275 | $224 |
| Research & Development | $266 | $262 | $264 | $272 | $261 | $254 |
| Provision for Doubtful Accounts | $4 | $2 | -$2 | -$1 | $5 | -$3 |
| Total Operating Expenses | $947 | $924 | $875 | $931 | $906 | $807 |
| Operating Income | $239 | $265 | $258 | $216 | $207 | $344 |
| Non-Operating | ||||||
| Net Interest Expense | – | – | – | – | $6 | $3 |
| Other Non-Operating Income (Expense) | $38 | $39 | $54 | $34 | $3 | $7 |
| EBT (Earnings Before Tax) | $277 | $303 | $312 | $250 | $215 | $355 |
| Income Tax Expense | $49 | $47 | $48 | $48 | $31 | $37 |
| Minority Interest | – | – | – | – | -$0 | $8 |
| Net Income | ||||||
| Net Income | $226 | $255 | $262 | $201 | $184 | $310 |
| Per Share Data | ||||||
| Revenue Per Share | $14.33 | $13.84 | $13.09 | $13.30 | $12.29 | $12.25 |
| EPS (Basic) | $2.38 | $2.66 | $2.74 | $2.10 | $1.84 | $3.07 |
| EPS (Diluted) | $2.34 | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 |
| Weighted Avg Shares (Basic) | 94.2M | 95.9M | 95.5M | 95.8M | 100.0M | 101.2M |
| Weighted Avg Shares (Diluted) | 94.5M | 97.5M | 97.3M | 97.7M | 102.0M | 104.6M |
| Shares Outstanding | 94.5M | 97.5M | 97.3M | 97.7M | 102.0M | 104.6M |
| Dividends Per Share | $1.41 | $1.32 | $1.20 | $1.08 | $1.00 | $0.88 |
Dolby Laboratories (DLB) financials: revenue, profit and margins
Dolby Laboratories (DLB) generated about $1.4 billion in revenue and $226 million in net income (a 16.7% net margin) over the trailing twelve months, growing at roughly 3.0% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is Dolby Laboratories's (DLB) revenue?+
Dolby Laboratories generated about $1.4 billion in revenue over the trailing twelve months. Revenue has grown at roughly 3.0% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Dolby Laboratories profitable?+
Yes, Dolby Laboratories reported about $226 million in net income over the trailing twelve months, a net profit margin of roughly 16.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Dolby Laboratories's profit margins?+
Dolby Laboratories runs a gross margin of about 87.6%, an operating margin of about 17.7%, a net margin of about 16.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Dolby Laboratories growing?+
Dolby Laboratories's revenue has compounded at roughly 3.0% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside DLB's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 30 Jul 2026, covering the period ending 26 Jun 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.
Fiscal year ends Sep.
Peers
Patent Owners & Lessors · Pick stocks to compare with DLB
Held by ETFs
DLB is in 134 US ETFs. The largest of them, with DLB's weight in each:
Spot a number that looks wrong? Check it in DLB's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DLB
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.